[FGF23 and osteonetwork].
Copyright policy )[FGF23 and osteonetwork].
Fibroblast growth factor 23(FGF23)is produced mainly by osteocytes and works as a hormone that reduces serum phosphate level in a Klotho-dependent manner. The identification of FGF23 revealed that bone works as an endocrine organ. On the other hand, FGF23 has been shown to be high in patients with chronic kidney disease and suggested to cause several adverse events including left ventricular hypertrophy and impaired immune function in a Klotho-independent manner. However, it is not known how FGF23 can work without Klotho.
- University of Tokushima Japan
Fibroblast Growth Factors, Fibroblast Growth Factor-23, Animals, Humans, Renal Insufficiency, Chronic, Klotho Proteins, Bone and Bones, Glucuronidase, Phosphates
Fibroblast Growth Factors, Fibroblast Growth Factor-23, Animals, Humans, Renal Insufficiency, Chronic, Klotho Proteins, Bone and Bones, Glucuronidase, Phosphates
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!